Transforming Science into Medicine

아이디언스 항암제 후보물질 IDX-1197 美FDA IND 통과
아이디언스, 330억원 투자유치 성공
Idience is a science-driven biopharmaceutical company that changes oncology patients’ quality of life.

LEADERSHIP TEAM

Meet the leadership team at Idience

CAREERS

Join our team if you share our values, our dedication to patients and our passion for science

PIPELINE

Learn about our key pipeline of PARP inhibitor

CLINICAL PROGRAMS

Explore our clinical trials of PARP inhibitor

logo.png

Contact​

info@idience.com

Phone +82-2-526-3622

Fax +82-2-526-3620

2, Baumoe-ro 27-gil, Seocho-gu,

Seoul 06752

Korea

All rights reserved. Idience Co., Ltd